Invesco S&P 500 Low Volatility ETF

SPLV

Market cap $8.1B

In a notable shift for the start of 2026, the S&P 500 is experiencing a divergence in factor performance. Typically, high beta (aggressive, high-risk) and low volatility (defensive, safe-haven) factors sit on opposite sides of the seesaw.

The Invesco S&P 500 Low Volatility ETF (SPLV) was launched on May 5, 2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Large Cap Blend segment of the US equity market.

China's reported move to curb U.S. Treasury exposure lifts yields and raises fiscal concerns. Here are ETF strategies investors can consider now.

Though the stock market has generally continued its upward trend so far in 2026, cracks may be appearing. A slowing labor market, the risk of an AI bubble collapse, and a Cyclically Adjusted Price-to-Earnings (CAPE) ratio around 40 all suggest that a crash may be looming for a market that is potentially overvalued.

USMV and other low-volatility ETFs gain appeal as an AI-driven tech rout wipes $1T, spikes VIX, and fuels rotation into staples and value sectors.

SPY, perhaps the best known ETF and a standard bearer for the ETF ecosystem overall, launched 33 years ago today. The SPDR S&P 500 ETF Trust (SPY) holds just under $700 billion in AUM at press time, matching its historical significance with its sheer asset size.

When you look at dividend yields in the 2-4% range, you might think they are easy to dismiss as not being worth your time.

If you're interested in broad exposure to the Large Cap Blend segment of the US equity market, look no further than the Invesco S&P 500 Low Volatility ETF (SPLV), a passively managed exchange traded fund launched on May 5, 2011.

There are easy and inexpensive ways to broaden your stock market exposure, even within the S&P 500.

The latest jobs report has put the ETF market into a dilemma. With the unemployment rate rising to 4.4%, the highest level since October 2021, and December rate-cut odds shrinking to 28%, trimming risk and loading up on steadier, low-beta staples may prove to be a prudent move.